Effect of the USPSTF Grade D Recommendation against Screening for Prostate Cancer on Incident Prostate Cancer Diagnoses in the United States.
暂无分享,去创建一个
Sam S. Chang | D. Penson | D. Winchester | D. Barocas | A. Graves | K. Mallin | B. Palis
[1] B. Helfand,et al. Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation. , 2014, Urologic oncology.
[2] G. Andriole. Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer: Bill-Axelson A, Holmberg L, Garmo H, et al (Uppsala Univ Hosp, Sweden; et al) N Engl J Med 370:932-942, 2014 § , 2014 .
[3] R. Deyo,et al. ADAPTING A CLINICAL COMORBIDITY USE WITH ICD-g-CM ADMINISTRATIVE INDEX FOR DATABASES , 1992 .
[4] A. Renshaw,et al. The impact of a delay in initiating radiation therapy on prostate‐specific antigen outcome for patients with clinically localized prostate carcinoma , 2005, Cancer.
[5] D. Penson,et al. Racial variation in the pattern and quality of care for prostate cancer in the USA: mind the gap , 2010, BJU international.
[6] Monique J. Roobol,et al. Mortality Results from a Randomized ProstateCancer Screening Trial , 2009 .
[7] W. Shadish,et al. Experimental and Quasi-Experimental Designs for Generalized Causal Inference , 2001 .
[8] A K Wagner,et al. Segmented regression analysis of interrupted time series studies in medication use research , 2002, Journal of clinical pharmacy and therapeutics.
[9] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[10] R. Deyo,et al. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.
[11] V. Moyer,et al. Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2012, Annals of Internal Medicine.
[12] Ruth Etzioni,et al. Long-term projections of the harm-benefit trade-off in prostate cancer screening are more favorable than previous short-term estimates. , 2011, Journal of clinical epidemiology.
[13] Ruth Etzioni,et al. Overdiagnosis and overtreatment of prostate cancer. , 2014, European urology.
[14] David Chia,et al. Mortality results from a randomized prostate-cancer screening trial. , 2009, The New England journal of medicine.
[15] Monique J. Roobol,et al. Re: Mortality Results from a Randomized Prostate-Cancer Screening Trial , 2009 .
[16] A. Jemal,et al. Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.
[17] C. Ko,et al. The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States , 2008, Annals of Surgical Oncology.
[18] A. Evans,et al. Delay in surgical therapy for clinically localized prostate cancer and biochemical recurrence after radical prostatectomy. , 2003, The Canadian journal of urology.
[19] A D Mickalide,et al. U.S. Preventive Services Task Force. , 1986, Pediatric clinics of North America.
[20] Mohammad Hassan Murad,et al. Early detection of prostate cancer: AUA Guideline. , 2013, The Journal of urology.
[21] P. Glasziou,et al. Screening for colorectal cancer using the faecal occult blood test, hemoccult. , 2000, The Cochrane database of systematic reviews.
[22] Christina Bougatsos,et al. Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force , 2011, Annals of Internal Medicine.
[23] P. Carroll,et al. 20-year outcomes following conservative management of clinically localized prostate cancer , 2005 .
[24] H. Koenig,et al. Prostate-Specific Antigen-Based Screening for Prostate Cancer , 2011 .
[25] L. Ponsky,et al. The impact of recent screening recommendations on prostate cancer screening in a large health care system. , 2013, The Journal of urology.
[26] P. Maté Mate. [Radical prostatectomy versus observation for localized prostate cancer]. , 2013, Revista clinica espanola.
[27] M. Tonelli,et al. Recommendations on screening for prostate cancer with the prostate-specific antigen test , 2014, Canadian Medical Association Journal.
[28] Dante diTommaso,et al. Quantifying the role of PSA screening in the US prostate cancer mortality decline , 2008, Cancer Causes & Control.
[29] J. Kirkpatrick. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. , 1998, Journal of insurance medicine.
[30] D. Siemens. Radical prostatectomy or watchful waiting in early prostate cancer? , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[31] A. Evans,et al. Impact of the U.S. Preventive Services Task Force recommendations against prostate specific antigen screening on prostate biopsy and cancer detection rates. , 2015, The Journal of urology.
[32] P. Gøtzsche,et al. Screening for breast cancer with mammography. , 2013, The Cochrane database of systematic reviews.